Stocks›Healthcare›CCEL

CCEL Cryo-Cell International, Inc.

NYSEResearch view

Cryo-Cell International, Inc. operates in the Services-Misc Health & Allied Services, Nec industry.

$4.42+21.10%
Oct 16 close · 1D EOD · Databento
HealthcareServices-Misc Health & Allied Services, NecMicro-capSEC EDGAR FY 2025-11-30

On the WireNo stories on CCEL yet. Follow the company and the next one lands in Following.

The numbers · FY2025, filed

SEC EDGAR
Market cap$36M
Revenue$31.6M−1.30%
Net income$-2.4M
EPS, diluted$-0.30−700.00%
Operating margin1.5%
Return on equity13.1%
All filed figures

Snapshot

SEC EDGAR · FY 2025-11-30
SectorHealthcare
Market Cap$35.6M
Enterprise Value$43.7M
Income$-2.4M
Sales$31.6M
Book/sh$-2.31
Cash/sh$0.04
Dividend TTM$0.25
Payout-133%
Employees—
IPO—
Quick Ratio0.57
Current Ratio0.59
Debt/Eq-0.45
EPS (ttm)$-0.30
EPS this Y-700.0%
EPS past 3/5Y—
Sales past 3/5Y1.3%
EPS Y/Y TTM-700.0%
Sales Y/Y TTM-1.3%
Shs Outstand8.06M
ROA-3.9%
ROE13.1%
ROIC—
Gross Margin—
Oper. Margin1.5%
Profit Margin-7.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$28.9M
FY21
$30.3M
FY22
$31.3M
FY23
$32.0M
FY24
$31.6M
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%2%-8%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.